BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer

Joanne Kotsopoulos; Karla Willows; Sandra Trat; Raymond H. Kim; Alexandra Volenik; Ping Sun; Steven A. Narod; Jeffrey Boyd; Taymaa May

doi:10.1097/IGC.0000000000001144

Article info

Ovarian Cancer

BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer

Authors

Joanne Kotsopoulos Women's College Research Institute, Women's College Hospital; Dalla Lana School of Public Health, PubMed articles Google scholar articles
Karla Willows Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario; PubMed articles Google scholar articles
Sandra Trat Schulich School of Medicine and Dentistry, Western University, London; Division of Gynecologic Oncology, PubMed articles Google scholar articles
Raymond H. Kim Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada; PubMed articles Google scholar articles
Alexandra Volenik Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada; PubMed articles Google scholar articles
Ping Sun Women's College Research Institute, Women's College Hospital; PubMed articles Google scholar articles
Steven A. Narod Women's College Research Institute, Women's College Hospital; Dalla Lana School of Public Health, PubMed articles Google scholar articles
Jeffrey Boyd Herbert Wertheim College of Medicine, Florida International University; and Miami Cancer Institute, Baptist Health South Florida, Miami, FL. PubMed articles Google scholar articles
Taymaa May Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada; PubMed articles Google scholar articles

Address correspondence and reprint requests to Joanne Kotsopoulos, PhD, Women's College Research Institute, Women's College Hospital, 76 Grenville St, 6th Floor, Room 6423, Toronto, Ontario, Canada M5S 1B2. E-mail: joanne.kotsopoulos{at}wchospital.ca.

Citation

Kotsopoulos J, Willows K, Trat S, et al

BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer

International Journal of Gynecologic Cancer 2018;28:69-76.

Publication history

Received May 26, 2017
Accepted August 28, 2017
First published January 1, 2018.

Online issue publication

January 01, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password